Role of AIF-1 in the regulation of inflammatory activation and diverse disease processes

Cellular Immunology

Volumn 284, Issue 1-2, 2013, Pages 75-83

  Zhao, Yan Ying ^a   Yan, Dong Jing ^b   Chen, Zheng Wang ^c  

^a SOUTHWEST UNIVERSITY FOR NATIONALITIES   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

AIF 1; Disease processes; Inflammation; Migration; Proliferation

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; CHEMOKINE; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE;

AUTOIMMUNE DISEASE; BRAIN INJURY; GRAFT REJECTION; HUMAN; INFLAMMATION; INFLAMMATORY CELL; NEOPLASM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; VASCULAR DISEASE;

AIF-1; DISEASE PROCESSES; INFLAMMATION; MIGRATION; PROLIFERATION;

AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNE DISEASES; BASE SEQUENCE; DNA-BINDING PROTEINS; GRAFT REJECTION; HUMANS; INFLAMMATION; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT;

EID: 84882794566     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.07.008     Document Type: Review

References (61)

1. Chen Z.W., C.G.Ostenson, Bergman T. Isolation and structural analysis of a novel peptide daintain. Eur. J. Endocrinol. 1994, 130(Suppl. 2):32.
2. Chen Z.W., Ahen B., Ösenson C.G., Cintra A., Bergman T., Moller C., Fuxe K., Mutt V., Jornvall H., Efendic S. Identification, isolation, and characterization of daintain (allograft inflammatory factor 1), a macrophage polypeptide with effects on insulin secretion and abundantly present in the pancreas of prediabetic BB rats. Proc. Natl. Acad. Sci. 1997, 94:13879-13884.
3. Utans U., Arceci R.J., Yamashita Y., Russell M.E. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J. Clin. Invest. 1995, 95:2954-2962.
4. Utans U., Quist W.C., McManus B.M., Wilson J.E., Arceci R.J., Wallace A.F., Russell M.E. Allograft inflammatory factory-1. A cytokine-responsive macrophage molecule expressed in transplanted human hearts. Transplantation 1996, 61:1387-1392.
5. Liu G.W., Mai H.X., Jiang L.L., Zhao Y. Allograft inflammatory factor-1 and its immune regulation. Autoimmunity 2007, 40:95-102.
6. Imai Y., Ibata I., Ito D., Ohsawa K., Kohsaka S. A novel gene iba1 in the major histocompatibiliy complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem. Biophys. Res. Commun. 1996, 224:855-862.
7. Tanaka S., Suzuki K., Watanabe M., Matsuda A., Tone S., Koike T. Up-regulation of a new microglial gene, mrf-1, in response to programmed neuronal cell death and degeneration. J. Neurosci. 1998, 18:6358-6369.
8. Deininger M.H., Meyermann R., Schluesener H.J. The allograft inflammatory factor-1 family of proteins. FEBS Lett. 2002, 514:115-121.
9. Iris F.M.J., Bougueleret L., Prieur S., Caterina D., Primas G., Perrot V., Jurka J., Rodriguez-Tome P., Claverie J.M., Dausset J., Cohen D. Dense Alu clustering and a potential new member of the NF-κB family within a 90 kilobase HLA class III segment. Nat. Genet. 1993, 3:137-145.
10. Hung A.Y., Sheng M. PDZ domains: structural modules for protein complex assembly. J. Biol. Chem. 2002, 277:5699-5702.
11. Chen J., DeVivo M., Dingus J., Harry A., Li J., Sui J., Carty D.J., Blank J.L., Exton J.H., Stoffel R.H., Inglese J., Lefkowitz R.J., Logothetis D.E., Hildebrandt J.D., Iyengar R. A region of adenylyl cyclase 2 critical for regulation by G protein beta gamma subunits. Science 1995, 268:1166-1169.
12. Autieri M.V. CDNA cloning of human allograft inflammatory factor-1: tissue distribution, cytokine induction, and mRNA expression in injured rat carotid arteries. Biochem. Biophys. Res. Commun. 1996, 228:29-37.
13. Köhler C. Allograft inflammatory factor-1/Ionized calcium-binding adapter molecule 1 is specifically expressed by most subpopulations of macrophages and spermatids in testis. Cell Tissue Res. 2007, 330:291-302.
14. Watano K., Iwabuchi K., Fujii S., Ishimori N., Mitsuhashi S., Ato M., Kitabatake A., Onoé K. Allograft inflammatory factor-1 augments production of interleukin-6, -10 and -12 by a mouse macrophage line. Immunology 2001, 104:307-316.
15. Tian Y., Kelemen S.E., Autieri M.V. Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli. Am. J. Physiol. Cell Physiol. 2006, 290:C1083-C1091.
16. Yang Z.F., Ho D.W., Lau C.K., Lam C.T., Lum C.T., Poon R.T., Fan S.T. Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages. Int. Immunol. 2005, 17:1391-1397.
17. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
18. Zhao Y.Y., Chen Z.W. Daintain invokes oxidative stress in blood. J. Southwest Univ. Nationalities 2011, 37:422-424.
19. Zhao Y.Y., Wang J.H., Chen Z.W. Macrophage cytokine daintain stimulates inflammatory reaction in the blood. Nat. Prod. Res. Dev. 2011, 23:425-427.
20. Mishima T., Iwabuchi K., Fujii S., Tanaka S.Y., Ogura H., Watano-Miyata K., Ishimori N., Andoh Y., Nakai Y., Iwabuchi C., Ato M., Kitabatake A., Tsutsui H., Onoé K. Allograft inflammatory factor-1 augments macrophage phagocytotic activity and accelerates the progression of atherosclerosis in ApoE-/- mice. Int. J. Mol. Med. 2008, 21:181-187.
21. Del Galdo F., Jimenez S.A. T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro. Arthritis Rheum. 2007, 56:3478-3488.
22. Yan D.J., Chen Z.W. 17β-Estradiol increased the expression of daintain/AIF-1 in RAW264.7 macrophages. Biosci. Biotechnol. Biochem. 2010, 74:2103-2105.
23. Nagakawa Y., Nomoto S., Kato Y., Montgomery R.A., Williams G.M., Klein A.S., Sun Z. Over-expression of AIF-1 in liver allografts and peripheral blood correlates with acute rejection after transplantation in rats. Am. J. Transplant. 2004, 4:1949-1957.
24. Orsmark C., Skoog T., Jeskanen L., Kere J., Saarialho-Kere U. Expression of allograft inflammatory factor-1 in inflammatory skin disorders. Acta Derm. Venereol. 2007, 87:223-227.
25. Del Galdo F., Maul G.G., Jimenez S.A., Artlett C.M. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta. Arthritis Rheum. 2006, 54:2616-2625.
26. Yang Z.F., Ho D.W., Ngai P., Lau C.K., Zhao Y., Poon R.T., Fan S.T. Anti- inflammatory properties of IL-10 rescue small-for-size liver grafts. Liver Transpl. 2007, 13:558-565.
27. Chen Q.R., Guan F., Yan D.J., Lei D.S., Fu L., Xia H.S., Zhu Y.H., Chen Z.W., Niu A.O. The dynamic expression of allograft inflammatory factor-1 in hepatic tissues and splenic cells of BALB/c mice with Schistosoma japonicum infection. Tissue Antigens 2012, 79:33-41.
28. Berglund L.M., Kotova O., Osmark P., Grufman H., Xing C., Lydrup M.L., Goncalves I., Autieri M.V., Gomez M.F. NFAT regulates the expression of AIF-1 and IRT-1: yin and yang splice variants of neointima formation and atherosclerosis. Cardiovasc. Res. 2012, 93:414-423.
29. Autieri M.V., Kelemen S., Thomas B.A., Feller E.D., Goldman B.I., Eisen H.J. Allograft inflammatory factor-1 expression correlates with cardiac rejection and development of cardiac allograft vasculopathy. Circulation 2002, 106:2218-2223.
30. Zhou X., He Z., Henegar J., Allen B., Bigler S. Expression of allograft inflammatory factor-1 (AIF-1) in acute cellular rejection of cardiac allografts. Cardiovasc. Pathol. 2011, 20:177-184.
31. Raisanen-Sokolowski A., Glysing-Jensen T., Mottram P.L., Russell M.E. Sustained anti-CD4/CD8 treatment blocks inflammatory activation and intimal thickening in mouse heart allografts. Arterioscler. Thromb. Vasc. Biol. 1997, 17:2115-2122.
32. McDaniel D.O., Rigney D.A., McDaniel K.Y., Windham W.J., Redmond P., Williams B., Zhou X., Hawxby A., Butt F. Early expression profile of inflammatory markers and kidney allograft status. Transplant. Proc. 2013, 45:1520-1523.
33. Grimm P.C., McKenna R., Nickerson P., Russell M.E., Gough J., Gospodarek E., Liu B., Jeffery J., Rush D.N. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. Am. Soc. Nephrol. 1999, 10:1582-1589.
34. Kimura M., Kawahito Y., Obayashi H., Ohta M., Hara H., Adachi T., Tokunaga D., Hojo T., Hamaguchi M., Omoto A., Ishino H., Wada M., Kohno M., Tsubouchi Y., Yoshikawa T. A critical role for allograft inflammatory factor-1 in the pathogenesis of rheumatoid arthritis. J. Immunol. 2007, 178:3316-3322.
35. Liu Y., Mei C., Du R., Shen L. Protective effect of allograft inflammatory factor-1 on the apoptosis of fibroblast-like synoviocytes in patients with rheumatic arthritis induced by nitro oxide donor sodium nitroprusside. Scand. J. Rheumatol. 2013, April 2 Epub ahead of print.
36. Storch M.K., Weissert R., Steffer A., Birnbacher R., Wallstrom E., Dahlman I., Ostensson C.G., Linington C., Olsson T., Lassmann H. MHC gene related effects on microglia and macrophages in experimental autoimmune encephalomyelitis determine the extent of axonal injury. Brain Pathol. 2002, 12:287-299.
37. Schluesener H.J., Seid K., Meyermann R. Effects of autoantigen and dexamethasone treatment on expression of endothelialmonocyte activating polypeptide II and allograft-inflammatory factor-1 by activated macrophages and microglial cells inlesions of experimental autoimmune encephalomyelitis, neuritis and uveitis. Acta Neuropathol. (Berl.) 1999, 97:119-126.
38. Beiter T., Artelt M.R., Trautmann K., Schluesener H.J. Experimental autoimmune neuritis induces differential microglia activation in the rat spinal cord. J. Neuroimmunol. 2005, 160:25-31.
39. Pashenkov M., Efendic S., Zhu J., Zou L.P., Ostenson C.G., Mustafa M. Augmented expression of daintain/allograft inflammatory factor-1 is associated with clinical disease: dynamics of daintain/allograft inflammatory factor-1 expression in spleen, peripheral nerves and sera during experimental autoimmune neuritis. Scand. J. Immunol. 2000, 52:117-122.
40. Eike M.C., Olsson M., Undlien D.E., Dahl-Jørgensen K., Joner G., Rønningen K.S., Thorsby E., Lie B.A. Genetic variants of the HLA-A, HLA-B and AIF1 loci show independent associations with type 1 diabetes in Norwegian families. Genes Immun. 2009, 10:141-150.
41. Zhao Y.Y., Huang X.Y., Chen Z.W. Daintain/AIF-1 (Allograft Inflammatory Factor-1) accelerates type 1 diabetes in NOD mice. Biochem. Biophys. Res. Commun. 2012, 427:513-517.
42. Huang X.Y., Zhao Y.Y., Jia S.H., Yan D.J., Chen Z.W. Effects of daintain/AIF-1 on β cell dysfunction in INS-1 cells. Biosci. Biotechnol. Biochem. 2011, 75:1842-1844.
43. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352:1685-1695.
44. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
45. Kelemen S.E., Autieri M.V. Expression of allograft inflammatory factor-1 in T lymphocytes: a role in T-lymphocyte activation and proliferative arteriopathies. Am. J. Pathol. 2005, 167:619-626.
46. Autieri M.V., Carbone C.M. Overexpression of allograft inflammatory factor-1 promotes proliferation of vascular smooth muscle cells by cell cycle deregulation. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1421-1426.
47. Autieri M.V., Carbone C.J., Eisen H. The growth enhancing effects of allograft inflammatory Factor-1 (AIF-1) in VSMC are dose-dependent and mediated by its ability to bind calcium. J. Heart Lung Transplant. 2001, 20:198.
48. Chen X., Kelemen S.E., Autieri M.V. AIF-1 expression modulates proliferation of human vascular smooth muscle cells by autocrine expression of G-CSF. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1217-1222.
49. Autieri M.V., Kelemen S.E., Wendt K.W. AIF-1 is an actin-polymerizing and Rac1-activating protein that promotes vascular smooth muscle cell migration. Circ. Res. 2003, 92:1107-1114.
50. Tian Y., Autieri M.V. Cytokine expression and AIF-1-mediated activation of Rac2 in vascular smooth muscle cells: a role for Rac2 in VSMC activation. Am. J. Physiol. Cell Physiol. 2007, 292:C841-C849.
51. Sommerville L.J., Kelemen S.E., Autieri M.V. Increased smooth muscle cell activation and neointima formation in response to injury in AIF-1 transgenic mice. Arterioscler. Thromb. Vasc. Biol. 2008, 28:47-53.
52. Sommerville L.J., Kelemen S.E., Ellison S.P., England R.N., Autieri M.V. Increased atherosclerosis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet. Atherosclerosis 2012, 220:45-52.
53. Tian Y., Jain S., Kelemen S.E., Autieri M.V. AIF-1 expression regulates endothelial cell activation, signal transduction, and vasculogenesis. Am. J. Physiol. Cell Physiol. 2009, 296:C256-C266.
54. Postler E., Rimner A., Beschorner R., Schluesener H.J., Meyermann R. Allograft-inflammatory-factor-1 is upregulated in microglial cells in human cerebral infarctions. J. Neuroimmunol. 2000, 104:85-91.
55. Deininger M.H., Weinschenk T., Meyermann R., Schluesener H.J. The allograft inflammatory factor-1 in Creutzfeldt-Jakob disease brains. Neuropathol. Appl. Neurobiol. 2003, 29:389-399.
56. Herden C., Schluesener H.J., Richt J.A. Expression of allograft inflammatory factor-1 and haeme oxygenase-1 in brains of rats infected with the neurotropic Borna disease virus. Neuropathol. Appl. Neurobiol. 2005, 31:512-521.
57. Deininger M.H., Seid K., Engel S., Meyermann R., Schluesener H.J. Allograft inflammatory factor-1 defines a distinct subset of infiltrating macrophages/microglial cells in rat and human gliomas. Acta Neuropathol. 2000, 100:673-680.
58. Jia J., Cai Y., Wang R., Fu K., Zhao Y.F. Overexpression of allograft inflammatory factor-1 promotes the proliferation and migration of human endothelial cells (HUV-EC-C) probably by up-regulation of bFGF. Pediatr. Res. 2010, 67:29-34.
59. Jia J., Bai Y., Fu K., Sun Z.J., Chen X.M., Zhao Y.F. Expression of allograft inflammatory factor-1 and CD68 in haemangioma: implication in the progression of haemangioma. Br. J. Dermatol. 2008, 159:811-819.
60. Liu S., Tan W.Y., Chen Q.R., Chen X.P., Fu K., Zhao Y.Y., Chen Z.W. Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kB/cyclin D1 pathway and facilitates tumor growth. Cancer Sci. 2008, 99:952-957.
61. Li T., Feng Z.G., Jia S.H., Wang W., Du Z., Chen N., Chen Z. Daintain/AIF-1 promotes breast cancer cell migration by up-regulated TNF-α via activate p38 MAPK signaling pathway. Breast Cancer Res. Treat. 2012, 131:891-898.